Why is JFL Life falling/rising?

As of 12-Sep, JFL Life Sciences Ltd is experiencing a decline in its stock price, currently at Rs 13.00, which reflects a decrease of Rs 0.05 or 0.38%. The stock has underperformed significantly, with a 1-week return of -9.09% and a year-to-date return of -57.72%. Today's performance indicates that it is trading below all key moving averages, and there has been a notable drop in investor participation, with delivery volume falling by 56.52% compared to the 5-day average. Despite a healthy long-term growth in operating profit at an annual rate of 34.76%, the stock's performance has been hindered by flat results in recent quarters and a substantial decline in net sales. In the broader market context, JFL Life's performance has been consistently poor compared to the benchmark, with a 1-year return of -80.35% against a slight decline of -1.08% for the Sensex. This consistent underperformance over the last three years has contributed to a lack of investor confidence, further exacerbated by the stock's current trading position, which is just 1.92% above its 52-week low. While the company has a strong return on capital employed (ROCE) of 14.4 and an attractive valuation, these factors have not been sufficient to offset the negative sentiment surrounding its recent financial results and overall market performance.